DE3688900T2 - Expression von Protein C. - Google Patents

Expression von Protein C.

Info

Publication number
DE3688900T2
DE3688900T2 DE86304970T DE3688900T DE3688900T2 DE 3688900 T2 DE3688900 T2 DE 3688900T2 DE 86304970 T DE86304970 T DE 86304970T DE 3688900 T DE3688900 T DE 3688900T DE 3688900 T2 DE3688900 T2 DE 3688900T2
Authority
DE
Germany
Prior art keywords
protein
nucleotide sequence
disclosed
mammalian host
biological activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE86304970T
Other languages
English (en)
Other versions
DE3688900D1 (de
DE3688900T3 (de
Inventor
Mark J Murray
Kathleen L Berkner
Donald C Foster
Earl W Davie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Zymogenetics Inc
Original Assignee
University of Washington
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27115147&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3688900(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/766,109 external-priority patent/US4968626A/en
Application filed by University of Washington, Zymogenetics Inc filed Critical University of Washington
Publication of DE3688900D1 publication Critical patent/DE3688900D1/de
Publication of DE3688900T2 publication Critical patent/DE3688900T2/de
Application granted granted Critical
Publication of DE3688900T3 publication Critical patent/DE3688900T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
DE3688900T 1985-06-27 1986-06-26 Expression von Protein C. Expired - Lifetime DE3688900T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74960085A 1985-06-27 1985-06-27
US06/766,109 US4968626A (en) 1985-08-15 1985-08-15 DNA sequence coding for protein C

Publications (3)

Publication Number Publication Date
DE3688900D1 DE3688900D1 (de) 1993-09-23
DE3688900T2 true DE3688900T2 (de) 1993-12-09
DE3688900T3 DE3688900T3 (de) 1998-06-10

Family

ID=27115147

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3688900T Expired - Lifetime DE3688900T3 (de) 1985-06-27 1986-06-26 Expression von Protein C.

Country Status (7)

Country Link
EP (1) EP0215548B2 (de)
JP (2) JP2614848B2 (de)
AT (1) ATE93272T1 (de)
CA (1) CA1341228C (de)
DE (1) DE3688900T3 (de)
DK (1) DK175574B1 (de)
NO (1) NO305660B1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US5550036A (en) * 1986-04-09 1996-08-27 Eli Lilly And Company Method for co-amplification of human protein C genes in human cells
USH1148H (en) 1987-04-17 1993-03-02 Method of separating activated human protein C
JP2799316B2 (ja) * 1987-06-12 1998-09-17 ヘキスト・マリオン・ルセル株式会社 雑種ヒトプロテインｃおよびその遺伝子工学的製法
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US5196322A (en) * 1987-12-28 1993-03-23 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
WO1991002065A1 (en) * 1989-08-11 1991-02-21 Zymogenetics, Inc. Cell culture methods for producing activated protein c
JP2774156B2 (ja) * 1989-09-05 1998-07-09 帝人株式会社 ヒトプロテインｃおよび／または活性化ヒトプロテインｃ様活性を有する蛋白
JP2774163B2 (ja) * 1989-11-14 1998-07-09 帝人株式会社 ヒトプロテインｃ様活性を有する蛋白
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
DE69032029T2 (de) * 1989-12-29 1998-08-20 Zymogenetics Inc Hybrides protein c
US5270178A (en) * 1990-02-23 1993-12-14 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
US5443968A (en) * 1992-05-01 1995-08-22 Teijin Limited Fed batch culture method for protein secreting cells
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5561053A (en) * 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
AU1751801A (en) * 1999-11-19 2001-05-30 Eli Lilly And Company Protein c derivatives
CA2609435A1 (en) * 2005-05-24 2006-11-30 Avestha Gengraine Technologies Pvt Ltd. A process comprising codon optimization for the production of recombinant activated human protein c for the treatment of sepsis
CN104755020B (zh) 2012-10-23 2018-01-12 皇家飞利浦有限公司 精神压力测量系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
EP0215548A1 (de) 1987-03-25
ATE93272T1 (de) 1993-09-15
DK308586D0 (da) 1986-06-27
DK175574B1 (da) 2004-12-13
NO305660B1 (no) 1999-07-05
JPS62111690A (ja) 1987-05-22
EP0215548B1 (de) 1993-08-18
NO862601D0 (no) 1986-06-27
DE3688900D1 (de) 1993-09-23
JP2614848B2 (ja) 1997-05-28
JPH09107976A (ja) 1997-04-28
JP2688407B2 (ja) 1997-12-10
DK308586A (da) 1986-12-28
DE3688900T3 (de) 1998-06-10
CA1341228C (en) 2001-05-15
NO862601L (no) 1986-12-29
EP0215548B2 (de) 1998-01-07

Similar Documents

Publication Publication Date Title
NO874495D0 (no) Ekspresjon av protein c.
DE3688900D1 (de) Expression von protein c.
ATE391175T1 (de) Multidrug resistenz gen
FI963246A (fi) Geeniterapiassa käytettävä isäntävektorijärjestelmä
ATE88501T1 (de) Rekombinante dns-expressionsvektoren.
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
GR860984B (en) Expression of factor vii and ix activities in mammalian cells
FI98829B (fi) Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
DK127786D0 (da) Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertscellerindeholdende vektorerne
EP0111814A3 (de) Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
EP0835661A3 (de) Menslisches Interferon-Beta 2A zur Verwendung als Arzneimittel
ES2078243T3 (es) Mejoras en o relativas a la expresion eucariotica.
EP0336383A3 (de) Menschliches rekombinantes Lymphotoxin
AU6560886A (en) DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells
ATE181115T1 (de) Stabilisierung von messenger-rns in tierischen zellen
ATE111527T1 (de) Herstellung und verwendung einer dna zur erhöhung der ausbeute bei der expression von rekombinanten genen.
WO1991009951A3 (en) Recombinant protein c with truncated light chain

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings